These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives. Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670 [TBL] [Abstract][Full Text] [Related]
31. First-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma. Abdelkefi A; Torjman L; Ben Romdhane N; Ladeb S; El Omri H; Ben Othman T; Elloumi M; Bellaj H; Lakhal A; Jeddi R; Aissaouï L; Saad A; Hsaïri M; Boukef K; Dellagi K; Ben Abdeladhim A Bone Marrow Transplant; 2005 Aug; 36(3):193-8. PubMed ID: 15968290 [TBL] [Abstract][Full Text] [Related]
32. Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients. Holowiecki J; Grosicki S; Sadus-Wojciechowska M; Kachel L; Hellmann A; Mital A; Skotnicki AB; Piatkowska-Jakubas B; Jedrzejczak WW; Paluszewska M; Wach M; Marianska B; Wrzesien-Kus A; Krawczyk-Kulis M; Wojnar J Transplant Proc; 2005 Dec; 37(10):4482-7. PubMed ID: 16387150 [TBL] [Abstract][Full Text] [Related]
33. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience. Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD; Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891 [TBL] [Abstract][Full Text] [Related]
34. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation]. Tian H; Zhou SY Ai Zheng; 2002 Aug; 21(8):896-9. PubMed ID: 12478902 [TBL] [Abstract][Full Text] [Related]
35. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases]. Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021 [TBL] [Abstract][Full Text] [Related]
36. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A; Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114 [TBL] [Abstract][Full Text] [Related]
37. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770 [TBL] [Abstract][Full Text] [Related]
38. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815 [TBL] [Abstract][Full Text] [Related]